Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis.

[1]  S. Fargion,et al.  Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis. , 2012, World journal of gastroenterology.

[2]  M. Lidonnici,et al.  Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia. , 2012, Blood.

[3]  Qian Wu,et al.  TMPRSS6, but not TF, TFR2 or BMP2 variants are associated with increased risk of iron-deficiency anemia. , 2012, Human molecular genetics.

[4]  Pauline L. Lee,et al.  Severe microcytic anemia but increased erythropoiesis in mice lacking Hfe or Tfr2 and Tmprss6. , 2012, Blood cells, molecules & diseases.

[5]  Elizabeta Nemeth,et al.  Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. , 2011, The Journal of clinical investigation.

[6]  Michela Traglia,et al.  TMPRSS6 rs855791 modulates hepcidin transcription in vitro and serum hepcidin levels in normal individuals. , 2011, Blood.

[7]  D. Girelli,et al.  Association of HFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations , 2011, Journal of Medical Genetics.

[8]  C. López-Otín,et al.  Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. , 2011, Blood.

[9]  B. Bacon,et al.  Diagnosis and Management of Hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases , 2011, Hepatology.

[10]  M. Cappellini,et al.  Genetic variability of TMPRSS6 and its association with iron deficiency anaemia , 2010, British journal of haematology.

[11]  E. Galmozzi,et al.  Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease. , 2010, Journal of hepatology.

[12]  L. N. Valenti,et al.  Hemochromatosis in Italy in the last 30 years: Role of genetic and acquired factors , 2010, Hepatology.

[13]  L. Valenti,et al.  Tumorigenesis and Neoplastic Progression Iron-Dependent Regulation of MDM2 Influences p53 Activity and Hepatic Carcinogenesis , 2010 .

[14]  J. Mosser,et al.  A common SNP near BMP2 is associated with severity of the iron burden in HFE p.C282Y homozygous patients: a follow-up study. , 2010, Blood cells, molecules & diseases.

[15]  Toshiko Tanaka,et al.  A genome-wide association analysis of serum iron concentrations. , 2010, Blood.

[16]  D. Girelli,et al.  Reduced serum hepcidin levels in patients with chronic hepatitis C. , 2009, Journal of hepatology.

[17]  Ian H. Frazer,et al.  Common variants in TMPRSS6 are associated with iron status and erythrocyte volume , 2009, Nature Genetics.

[18]  Gonçalo Abecasis,et al.  Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels , 2009, Nature Genetics.

[19]  K. Finberg.  Iron-refractory iron deficiency anemia. , 2009, Seminars in hematology.

[20]  Gloria Velasco,et al.  Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis , 2009, Haematologica.

[21]  L. N. Valenti,et al.  Association between iron overload and osteoporosis in patients with hereditary hemochromatosis , 2008, Osteoporosis International.

[22]  N. Andrews,et al.  Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) , 2008, Nature Genetics.

[23]  L. Powell,et al.  Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis. , 2008, Blood.

[24]  J. Gollan,et al.  Iron‐mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol , 2007, Hepatology.

[25]  A. Pietrangelo.  Hemochromatosis: An endocrine liver disease , 2007, Hepatology.

[26]  J. Bruix,et al.  Management of hepatocellular carcinoma , 2005, Hepatology.

[27]  C. Datz,et al.  Association of myeloperoxidase promotor polymorphism with cirrhosis in patients with hereditary hemochromatosis. , 2005, Journal of hepatology.

[28]  E. Thomson,et al.  Hemochromatosis and iron-overload screening in a racially diverse population. , 2005, The New England journal of medicine.

[29]  D. Conte,et al.  The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis , 2004, Journal of Medical Genetics.

[30]  A. Pietrangelo.  Hereditary hemochromatosis--a new look at an old disease. , 2004, The New England journal of medicine.

[31]  H. El‐Serag,et al.  Serum Ferritin Level Predicts Advanced Hepatic Fibrosis among U.S. Patients with Phenotypic Hemochromatosis , 2003, Annals of Internal Medicine.

[32]  D. Oakes,et al.  Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients. , 2002, Blood cells, molecules & diseases.

[33]  P. Brissot,et al.  Venesection therapy of insulin resistance-associated hepatic iron overload. , 2001, Journal of hepatology.

[34]  L. N. Valenti,et al.  Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis. , 2001, Blood.

[35]  D. Girelli,et al.  Haemochromatosis in patients with β‐thalassaemia trait , 2000, British journal of haematology.

[36]  V. Felitti,et al.  The Effect of HFE Genotypes on Measurements of Iron Overload in Patients Attending a Health Appraisal Clinic , 2000, Annals of Internal Medicine.

[37]  P. Brissot,et al.  EASL International Consensus Conference on Haemochromatosis. , 2000, Journal of hepatology.

[38]  A. Pietrangelo.  EASL International Consensus Conference on Haemochromatosis , 2000 .

[39]  J. Olynyk,et al.  A population-based study of the clinical expression of the hemochromatosis gene. , 1999, The New England journal of medicine.

[40]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[41]  K. Ishak,et al.  Histological grading and staging of chronic hepatitis. , 1995 .

[42]  S. Fargion,et al.  Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis , 1994, Hepatology.

[43]  J. Stockman.  Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice , 2013 .

[44]  M. Mason,et al.  The type II transmembrane serine protease, matriptase-2: Possible links to cancer? , 2010, Anti-cancer agents in medicinal chemistry.

[45]  J. Stockman.  Iron-Overload–Related Disease in HFE Hereditary Hemochromatosis , 2009 .

[46]  S. Fargion,et al.  The hand arthropathy of hereditary hemochromatosis is strongly associated with iron overload. , 2008, The Journal of rheumatology.

[47]  Matthias W. Hentze,et al.  Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004 .